Five cases of confirmed multiple-drug overdose were previously screened and quantified by the West Virginia Office of the Chief Medical Examiner; 26 different drugs and metabolites were identified and quantified in blood at ≥ 10 ng/mL. In this study, whole blood from those five case samples was analyzed by a direct injection multi-stage mass spectrometric (MS n ) method to confirm the identity of 26 analytes at or above 10 ng/mL using 16 different deuterium-labeled internal standards. Samples were spiked with internal standards, precipitated with acetonitrile, and centrifuged. Samples were further diluted with either 0.1% formic acid or 0.1% ammonium hydroxide in methanol prior to injection into an electrospray ionization ion trap mass spectrometer (MS). Ions were monitored as MS-MS or MS 3 product ions. In all cases, analysis by MS-MS confirmed the presence of the drugs and metabolites when the internal standards were detected. Detection of characteristic MS 3 ions was used for further confirmation of the presence of parent drugs in all but three instances. Total analysis time was less than 1 h. Although only useful for qualitative or confirmatory purposes, this direct injection MS n method provides a simple and rapid confirmation of multiple drugs that have been previously identified and quantified by gas chromatographic-MS or liquid chromatographic-MS analytical methods.
Introduction
Forensic toxicology utilizes multiple methods to identify and quantify drugs of abuse in biological matrices. Typically, a screening method is first applied to forensic samples to identify the drugs present in the sample. An analytical method, usually gas chromatography-mass spectrometry (GC-MS) or liquid chromatography (LC)-MS, is then used to identify, quantify, and confirm the results from the screening method. The interfacing of chromatography with MS allows for selective identification and accurate quantitation by MS because the analytes are separated by chromatography from matrix contaminants and other analytes. Direct injection MS is an alternative to LC-MS in some instances (1) . Electrospray ionization (ESI) is a frequently used ionization technique for chromatography-interfaced MS for use in forensic toxicology. ESI is a soft ionization technique that transfers solubilized ions from the liquid phase to the gaseous phase with nominal fragmentation of the compound and allowing for analysis of the intact molecular ion (2) .
Matrix effects have a strong influence on spectral fidelity and quantitation when ESI-MS is used as a direct inlet method without chromatography or extensive sample preparation in the analysis of forensic samples from biological matrices. ESI is susceptible to ion suppression resulting from matrix effects (3), which is likely caused by the co-elution of nonvolatile matrix contaminants (e.g., salts) that compete for ionization and change the physical properties of the charged droplet prior to nebulization (4) . Without chromatography to isolate analytes from matrix contaminants, either laborious sample preparation or stable-isotope-labeled internal standards is used to ameliorate matrix effects. The logic for using stable labeled internal standards is that both the unlabeled and stable labeled analogues are equally suppressed by matrix effects and ratios of their signal intensities can be formed to obtain a qualitative estimate of the analyte concentration. When no chromatography is used, all compounds are simultaneously injected into the MS. Although ion suppression can occur between analytes and their co-eluting stable labeled internal standards, it has been shown that suppression of this type does not affect analyses (5) . In a previous study that used a rapid ESI-MS-MS method to identify fentanyl and norfentanyl in postmortem urine, analyte concentrations were estimated through the use of isotope-dilution methodologies using fentanyl-d 5 and norfentanyl-d 5 (1) . Ion suppression studies on fentanyl/fentanyl-d 5 showed no fluctuations in ion intensity ratios as ion suppression increased, demonstrating that both analytes and stable-isotope-labeled internal standards are equally affected by ion suppression caused by urinary constituents.
Numerous methods for the identification of abused drugs have used LC-MS or LC-MS-MS to screen for or identify and quantify multiple drugs of abuse in blood, plasma, urine, and saliva (6) (7) (8) (9) . Each of these multi-analyte methods have used extensive sample preparation and chromatographic approaches to purify the samples prior to mass spectrometric analysis.
In this study, the presence of drugs and metabolites in postmortem blood from five cases of multiple-drug overdose were confirmed using direct injection ESI-MS-MS and MS 3 . The West Virginia Office of the Chief Medical Examiner (WV OCME) previously identified and quantified a total of 40 drugs and metabolites at blood concentrations of at least 10 ng/mL in the five cases using either GC-MS or LC-MS. The 40 analytes were represented by 20 different drugs of abuse and 6 different metabolites of those parent drugs. Because the concentration of the 40 total analytes in the five cases were previously quantified by the WV OCME, a simple and rapid mass spectrometric method was developed to provide an additional mode of detection of drugs and metabolites, whose blood concentrations were ≥ 10 ng/mL, based on their known fragmentation patterns (6) . Deuterium-labeled internal standards were available for 16 of the 26 different drugs and metabolites known to be present. The internal standards served as a control for extraction from blood and ion suppression in the MS. It was hypothesized that if the MS-MS fragmentation pattern was identified for the spiked deuterium-labeled standards, then the drugs present in the blood should be able to be confirmed as well.
Experimental Materials
Methanol, acetonitrile, ammonium hydroxide, and formic acid were purchased from Fisher Chemical (Pittsburgh, PA) and were of HPLC or MS grade. A Finnigan LCQ DECA ESI ion trap MS using Xcalibur software (Thermo Fisher Scientific, Waltham, MA) was used to provide an additional mode of detection of previously identified drugs. A nitrogen gas generator (Parker-Balston, Haverhill, MA) was operated at 45 psi and used as the source of the sheath gas. Stock solutions of the following deuterium-labeled drugs were purchased from Cerilliant (Round Rock, TX) as 100 µg/mL free base equivalents in methanol: acetaminophen-d 4 6 . Stock solutions of the following drug standards were purchased from Cerilliant as 1 mg/mL free base equivalents in methanol: acetaminophen, alprazolam, benzoylecgonine, carisoprodol, citalopram HBr (100 µg/mL), cocaine HCl, cyclobenzaprine HCl, dextromethorphan, diazepam, ecgonine methyl ester, EDDP perchlorate, fentanyl HCl, fluoxetine HCl, hydrocodone, ibuprofen, meprobamate, methadone HCl, promethazine, quetiapine hemifumarate, norfentanyl oxalate, nortriptyline, venlafaxine HCl, and zolpidem hemitartrate. Postmortem whole blood from five cases of confirmed multidrug overdose deaths was obtained at autopsy by the WV OCME, and aliquots were provided for this study.
Sample preparation
A 200-µL aliquot of whole blood from each case sample was spiked only with deuterated internal standards of analytes known to be present from the WV OCME. The blood concentrations of all spiked internal standards were 10 ng/mL, consistent with the recommended minimal detectable urine concentrations proposed by the Society of Forensic Toxicologists Drug-Facilitated Sexual Assault Committee, by the addition of 10 µL of each 200 ng/mL deuterated internal standard working solution prepared in methanol. Samples were vortex mixed for 1 min prior to addition of 1 mL of acetonitrile to precipitate proteins and extract drugs, metabolites, and deuterium-labeled internal standards. Samples were again vortex mixed for 1 min and then immediately centrifuged on a desktop centrifuge (Eppendorf, Westbury, NY) for 5 min at 13,000 rpm. A 50-µL aliquot of the supernatant from each case was added to 200 µL of 0.1% formic acid in methanol and then directly injected into the ESI-MS operated in the positive ion mode using a syringe with a flow rate of 7 µL/min. A separate 50-µL aliquot for Case 5 was added to 200 µL of 0.1% NH 4 OH in methanol to deprotonate ibuprofen and then injected into the MS for analysis in the negative ion mode.
Methods
Working solutions of each drug, metabolite, and internal standard from Cerilliant were prepared in methanol. Case-specific standard samples prepared in water were created with analyte and internal standard concentrations of 100 ng/mL and 10 ng/mL, respectively, to optimize conditions for each MS-MS and MS 3 transition. Seven case-specific MS-MS methods using 61 selected reaction monitoring (SRM) transitions for 65 total drugs, metabolites, and internal standards were developed to confirm the identity of each drug previously quantified by the WV OCME as ≥ 10 ng/mL in blood. There were four instances where two drugs had the same parent ion but gave different MS-MS product ions. The SRM of m/z 285 in Case 1 monitored both promethazine and diazepam. Case 2 contained one SRM of m/z 278 that monitored both amitriptyline and venlafaxine and one SRM of m/z 264 that monitored both nortriptyline and norvenlafaxine. The SRM of m/z 285 in Case 4 monitored both promethazine and diazepam. Cases 4 and 5 were split into two methods to allow for optimal SRM conditions because of the larger number of transitions monitored. Run times were 5 min, with each SRM transition consisting of three microscans over a 200 ms scan time.
Five case-specific MS 3 methods were developed using 29 consecutive reaction monitoring (CRM) transitions on 29 parent drugs in the 5 cases, including the cocaine metabolites in Case 3. CRM transitions were optimized to obtain the maximum signal for the MS 3 fragment ion resulting from fragmentation of the parent molecular ion and the major MS-MS fragment ion. Parent drugs not included in MS 3 analyses were ibuprofen, which did not have a reliable MS 3 fragment ion as determined by standards, and acetaminophen in Case 2, the MS-MS fragment ion of which was poorly detected. The MS 3 method run times were 2 min, with each CRM consisting of three microscans over 200 ms scan times. Table I contains the mass-tocharge ratios for parent ions and MS-MS product ions of all 61 SRM transitions (representing 65 ions) and also the MS 3 massto-charge ratios for those 29 analytes. MS instrument conditions were consistent for each case method as follows: heated capillary temperature was set at 220ºC, capillary voltage at 20 V, spray voltage at 5.2 kV, sheath gas flow rate at 40 arbitrary units, SRM collision energies ranged from 25 to 40% for all MS-MS transitions, and CRM collision energies ranged from 25 to 35% for all MS 3 transitions.
Case histories
Case 1. The decedent is a 48-year-old female who was employed as a licensed practical nurse. One morning she stated she was not feeling well and stayed home from work. Her husband returned home to check on her about 9:30 a.m. and found her deceased on the kitchen floor. An autopsy, including toxicological analysis, was performed, and her cause of death was attributed to combined quetiapine, methadone, dextromethorphan, and promethazine intoxication. The manner of death was undetermined because of uncertain intentionality underlying the drug ingestion.
Case 2. The decedent, a 57-year-old female who was employed as a beautician, had undergone several back surgeries and was reportedly being treated for depression. Her son found her deceased in her secured residence. A 100 µg/h fentanyl patch was adherent to her left flank region with evidence of adhesive residue similarly located on the right flank. The cause of death was determined to be combined prescribed fentanyl, venlafaxine, amitriptyline, cyclobenzaprine, and zolpidem intoxication, and the manner was classified as accidental. Case 3. This case was that of a 33-year-old male who worked as a logger. After he had spent a night out drinking, his girlfriend found him lying supine in bed with a nasal plume present. He was reported to have had a history of prescription and non-prescription drug abuse. Toxicology revealed the presence of hydrocodone, alprazolam, citalopram, and cocaine metabolite benzoylecgonine in the blood. His cause of death was thrombosis of the left coronary artery with illicit and non-prescribed drug intoxication judged as a contributory factor. The manner of death was accidental.
Case 4. This case was that of a 33-year-old female who worked as a cashier and had a reported history of prescription drug abuse. According to friends, she had been up most of the day snorting drugs. They stated that she had cut up a "morphine 75 patch", mixed it with Tylenol, and snorted it. By 3:30 p.m., she became unresponsive, and emergency personnel arrived at the residence and were unsuccessful at resuscitating her. Toxicological analysis revealed the presence of fentanyl, diphenhydramine, alprazolam, diazepam, promethazine, and carisoprodol in the blood. The cause of death was combined non-prescribed drug intoxication, and the manner of death was accidental. Case 5. The decedent in this case was a 22-year-old female, who was the mother of two children. She had reportedly been treated for depression and insomnia and was known to abuse her sister's medications. Her husband reported that she seemed disoriented when she went to bed at approximately 11 p.m. and had labored breathing. At 6 a.m., her husband awoke to find her not breathing. Emergency personnel attempted resuscitation but were unsuccessful. Toxicology was preformed and her cause of death was found to be combined cocaine, methadone, dextromethorphan, alprazolam, diazepam, and fluoxetine intoxication. The manner of death was accidental.
Results
Whole blood from five cases of confirmed multi-drug overdose deaths was obtained at autopsy by the WV OCME. Each case was previously screened for drugs of abuse by enzyme multiplied immunoassay technique (EMIT) and then analyzed either by GC-MS or LC-MS to identify and quantify drugs and metabolites present. There were 40 total drugs and metabolites identified in the 5 cases, represented by 20 drugs of abuse and 6 metabolites, with blood concentrations at least 10 ng/mL. Drugs that were present in more than one case were methadone, diazepam, promethazine, acetaminophen, alprazolam, dextromethorphan, and the cocaine metabolites benzoylecgonine and EME. The concentration of each analyte detected, as quantified by the WV OCME as ≥ 10 ng/mL in blood, is provided in Table I . Direct injection MS-MS was performed on the five cases to identify each analyte based on the presence of its major MS-MS product ion relative to that of its corresponding internal standard, which was used as a control for extraction and ion suppression.
The major MS-MS product ions of all but one of the 40 analytes (parent drugs and metabolites) were detected, as were all but one of the 25 total deuterated internal standards (Table I) . Acetaminophen in Case 2 was the only analyte not determined of the 40 analytes, and acetaminophen-d 4 in Case 2 was the only internal standard not detected of the 25 standards. Total analysis time, from thawed samples to end of the seven casespecific MS-MS methods at 5 min each, was less than 1 h. Although not routinely necessary, analyses were performed in triplicate to increase confidence in the identification method. Table I displays the mass-to-charge ratio of the parent ion (MH + ) and the major MS-MS fragment ion as well as the proposed neutral loss of the molecule resulting from the SRM fragmentation.
To ensure the selectivity of this method for identifying each analyte and internal standard, a standard solution containing the 16 different deuterated internal standards was analyzed by the 7 case-specific MS-MS methods. The internal standard signals were identified by the appearance of their major MS-MS product ions for all 25 internal standard SRM transitions. Conversely, a case sample of blood was prepared without spiking with the corresponding deuterated internal standards to check for cross-talk or contaminating substances. The results of this experiment identified the major MS-MS product ions from the SRM transitions of the analytes, but not those of the internal standards. These spiking experiments suggest that MS-MS analyses provide selectivity and specificity that is sufficient to confirm the identity of the drugs and metabolites known to be present based on their unique MS-MS fragmentation patterns.
Further confirmation was performed on 29 analytes based on their MS 3 fragmentation patterns optimized from standard samples. The 29 analytes excluded deuterated internal standards, metabolites (except cocaine metabolites in Case 3, where no parent cocaine was detected by the WV OCME), ibuprofen in Case 5, which did not provide a reliable MS 3 fragment ion as determined from standards, and acetaminophen in Case 2, which was not determined because of poor detection of the drug and acetaminophen-d 4 using MS-MS. Table I displays the mass-tocharge ratios of the major fragment ion resulting from MS 3 . All but 3 analytes, namely alprazolam in Case 3, carisoprodol in Case 4, and fluoxetine in Case 5, were identified by their MS 3 product ions.
Discussion
The purpose of this study was to confirm the presence of drugs and metabolites from a previous quantitative analysis of postmortem blood from five multiple-drug overdose cases. The initial screening and analytical determinations were performed by the WV OCME using EMIT and GC-MS or LC-MS methods. It was desired here to confirm the identity of the 40 previously detected drugs and metabolites (with blood concentrations determined to be ≥ 10 ng/mL by the WV OCME) based on the presence of their major MS-MS product ions. Quantitation of the confirmed drugs was not assessed because it was previously performed by the WV OCME and this study was evaluated as a simple and rapid confirmatory method. A second confirmation step was also developed by performing MS 3 on 29 analytes to provide further structure proof.
Postmortem blood from the five cases of multi-drug overdoses was minimally prepared and rapidly analyzed to confirm the identity of 65 drugs, metabolites, and internal standards present, which corresponds to 40 analytes (drugs and metabolites) and 25 total deuterated internal standards. Some of the drugs detected were present in multiple cases. There were 61 SRM transitions needed to identify the 65 analytes and internal standards represented by 26 different drugs and metabolites and 16 different deuterated internal standards. Total analysis time from thawed samples to the end of the analysis was less than 1 h. This direct injection MS method confirmed the identity of all but one of the 40 analytes, with the exception being acetaminophen in Case 2. For the 16 different drugs and metabolites with deuterated internal standards, confirmation was based upon the presence of their major MS-MS product ions compared to their deuterated analogues. If the MS-MS product ion from the corresponding internal standard was identified, then that analyte identity was confirmed. The logic is that because the deuterated internal standards are essentially the same compound, except for the deuterium incorporation, both compounds will be extracted from the blood equally and equally susceptible to ion suppression in the MS. The 12 different analytes without deuterated internal standards were confirmed based on the next most structurally related deuterated internal standard. Acetaminophen in Case 2 was the only analyte not determined because both the drug and acetaminophen-d 4 were either poorly extracted from blood or ion suppression decreased signal intensity such that the MS-MS fragment ions were not detected above baseline (1, 5) .
Further confirmation was performed as a means of further identifying drugs based on their characteristic fragmentation patterns by utilizing the multi-stage MS (MS n ) capabilities of quadrupole ion trap instruments. The logic for performing MS 3 for further confirmation was the increased confidence of distinguishing a drug from a contaminant or background. This step was performed on all parent drugs except acetaminophen in Case 2, which was not determined by MS-MS because of poor detection of both drug and acetaminophen-d 4 , and ibuprofen in Case 5, which did not provide a reliable MS 3 fragment ion within the mass range of the instrument. The only metabolites fragmented by MS 3 were the cocaine metabolites in Case 3, where no parent cocaine was detected by the WV OCME. The analytes chosen for MS 3 confirmation were representative of the presence of drugs administered by the decedent.
Conclusions
This study confirmed the presence of all but one of the 40 drugs and metabolites that were previously identified and quantified in blood at ≥ 10 ng/mL by GC-MS or LC-MS analytical methods by the WV OCME by using a direct injection multi-stage (MS-MS and MS 3 ) MS method. Acetaminophen in Case 2 was the only analyte not determined because the acetaminophend 4 MS-MS fragment ion was not detected. The MS 3 confirmation step was performed on 29 analytes, where 26 analytes were confirmed based on the presence of their major MS 3 product ions. This simple and rapid MS method provided sufficient selectivity and sensitivity to confirm drugs and metabolites present in postmortem whole blood based on the presence of their MS-MS and/or MS 3 product ions.
